title: Steviol reduces MDCK Cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation.
abstract: Cyst enlargement in polycystic kidney disease (PKD) involves cAMP-activated proliferation of cyst-lining epithelial cells and transepithelial fluid secretion into the cyst lumen via cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. This study aimed to investigate an inhibitory effect and detailed mechanisms of steviol and its derivatives on cyst growth using a cyst model in Madin-Darby canine kidney (MDCK) cells. Among 4 steviol-related compounds tested, steviol was found to be the most potent at inhibiting MDCK cyst growth. Steviol inhibition of cyst growth was dose-dependent; steviol (100 microM) reversibly inhibited cyst formation and cyst growth by 72.53.6% and 38.2±8.5%, respectively. Steviol at doses up to 200 microM had no effect on MDCK cell viability, proliferation and apoptosis. However, steviol acutely inhibited forskolin-stimulated apical chloride current in MDCK epithelia, measured with the Ussing chamber technique, in a dose-dependent manner. Prolonged treatment (24 h) with steviol (100 microM) also strongly inhibited forskolin-stimulated apical chloride current, in part by reducing CFTR protein expression in MDCK cells. Interestingly, proteasome inhibitor, MG-132, abolished the effect of steviol on CFTR protein expression. Immunofluorescence studies demonstrated that prolonged treatment (24 h) with steviol (100 microM) markedly reduced CFTR expression at the plasma membrane. Taken together, the data suggest that steviol retards MDCK cyst progression in two ways: first by directly inhibiting CFTR chloride channel activity and second by reducing CFTR expression, in part, by promoting proteasomal degradation of CFTR. Steviol and related compounds therefore represent drug candidates for treatment of polycystic kidney disease.
authors.affiliation: Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
authors.forename: Chaowalit
authors.initials: C
authors.lastname: Yuajit
authors.forename: Sureeporn
authors.initials: S
authors.lastname: Homvisasevongsa
authors.forename: Lisa
authors.initials: L
authors.lastname: Chatsudthipong
authors.forename: Sunhapas
authors.initials: S
authors.lastname: Soodvilai
authors.forename: Chatchai
authors.initials: C
authors.lastname: Muanprasat
authors.forename: Varanuj
authors.initials: V
authors.lastname: Chatsudthipong
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001692:Biological Transport / Q000187:drug effects; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D002712:Chlorides / Q000378:metabolism; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D003560:Cysts / Q000473:pathology; D045786:Diterpenes, Kaurane / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D007690:Polycystic Kidney Diseases / Q000378:metabolism* / Q000473:pathology*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D059748:Proteolysis / Q000187:drug effects; D013997:Time Factors
chemical_list: D002712:Chlorides; D045786:Diterpenes, Kaurane; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C012042:steviol; D046988:Proteasome Endopeptidase Complex
references.citation: J Clin Invest. 2002 Dec;110(11):1651-8
references.pmid: 12464670
references.citation: Nucl Med Biol. 1996 Jan;23(1):97-100
references.pmid: 9004922
references.citation: Kidney Int. 2009 Jul;76(2):149-68
references.pmid: 19455193
references.citation: Rev Diabet Stud. 2006 Winter;3(4):189-99
references.pmid: 17487343
references.citation: Kidney Int. 2004 Sep;66(3):964-73
references.pmid: 15327388
references.citation: Mol Biol Cell. 2011 Aug 15;22(16):2797-809
references.pmid: 21697503
references.citation: J Agric Food Chem. 2006 Feb 8;54(3):785-9
references.pmid: 16448183
references.citation: BioDrugs. 2009;23(4):203-16
references.pmid: 19697963
references.citation: Biochim Biophys Acta. 2011 Oct;1812(10):1291-300
references.pmid: 21118718
references.citation: Biochim Biophys Acta. 2011 Oct;1812(10):1314-21
references.pmid: 21255645
references.citation: Nat Rev Drug Discov. 2009 Feb;8(2):153-71
references.pmid: 19153558
references.citation: J Biol Chem. 1994 Oct 14;269(41):25710-8
references.pmid: 7523390
references.citation: Kidney Int. 2003 Jun;63(6):1983-94
references.pmid: 12753285
references.citation: PPAR Res. 2010;2010:274376
references.pmid: 21052534
references.citation: Physiol Rev. 1998 Oct;78(4):1165-91
references.pmid: 9790573
references.citation: J Agric Food Chem. 2003 Oct 22;51(22):6618-22
references.pmid: 14558786
references.citation: Nat Clin Pract Nephrol. 2006 Jan;2(1):40-55; quiz 55
references.pmid: 16932388
references.citation: Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C67-76
references.pmid: 21940661
references.citation: Planta Med. 2001 Dec;67(9):796-9
references.pmid: 11745013
references.citation: Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1176-86
references.pmid: 22874761
references.citation: World Health Organ Tech Rep Ser. 2006;934:1-145, back cover
references.pmid: 17069402
references.citation: Physiol Genomics. 2010 Aug;42(3):480-5
references.pmid: 20571109
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15370-5
references.pmid: 17873061
references.citation: Pharmacol Ther. 2009 Jan;121(1):41-54
references.pmid: 19000919
references.citation: J Pharmacol Exp Ther. 2001 Sep;298(3):1120-7
references.pmid: 11504809
references.citation: J Pharm Sci. 2011 Sep;100(9):3602-19
references.pmid: 21567408
references.citation: Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L304-14
references.pmid: 20008117
references.citation: Phytochemistry. 2003 Nov;64(5):913-21
references.pmid: 14561506
references.citation: Kidney Int. 1996 Jul;50(1):208-18
references.pmid: 8807590
references.citation: J Am Soc Nephrol. 2002 Sep;13(9):2384-98
references.pmid: 12191984
references.citation: Toxicon. 2011 May;57(6):932-7
references.pmid: 21419152
references.citation: Chest. 2011 Jun;139(6):1480-1490
references.pmid: 21652558
references.citation: Pharm Res. 2005 Jun;22(6):858-66
references.pmid: 15948029
references.citation: Eur J Clin Invest. 1996 Jun;26(6):506-13
references.pmid: 8817166
references.citation: J Gen Physiol. 2004 Aug;124(2):125-37
references.pmid: 15277574
references.citation: Kidney Int. 2004 Nov;66(5):1926-38
references.pmid: 15496164
references.citation: Eur J Pharmacol. 2011 Mar 1;654(1):92-9
references.pmid: 21187084
references.citation: Acta Pharmacol Sin. 2011 May;32(5):619-25
references.pmid: 21499287
references.citation: Am J Physiol Renal Physiol. 2009 Jul;297(1):F55-62
references.pmid: 19403648
references.citation: Food Chem Toxicol. 2008 Jul;46 Suppl 7:S54-60
references.pmid: 18555578
references.citation: J Pharmacol Exp Ther. 2008 Feb;324(2):798-805
references.pmid: 18032573
references.citation: J Am Soc Nephrol. 2008 Jul;19(7):1300-10
references.pmid: 18385427
references.citation: Proc Natl Acad Sci U S A. 1989 Aug;86(15):6007-11
references.pmid: 2474825
references.citation: Oncol Rep. 2011 Jun;25(6):1705-12
references.pmid: 21399877
references.citation: Am J Physiol Cell Physiol. 2001 Jan;280(1):C135-45
references.pmid: 11121385
references.citation: J Biol Chem. 2009 Feb 13;284(7):4168-78
references.pmid: 19098309
references.citation: J Biol Chem. 2002 Apr 5;277(14):11709-14
references.pmid: 11812794